G1-S

GLP-1 Receptor Agonist | Metabolic & Glucose Regulation Research Compound

For Research Use Only. Not for human or veterinary use. Not a drug, supplement, or food additive.

Intended exclusively for in-vitro and laboratory research by qualified investigators.

Semaglutide – 5mg / 10mg / 20mg
A Long-Acting GLP-1 Receptor Agonist for Metabolic and Glucose Regulation Research

Category: Peptide Research Compounds / Metabolic Research / Incretin Biology

Disclaimer

ATTENTION: PrimalResearchLabs.com products are intended for laboratory research and in-vitro studies only. All information presented is for educational and research purposes related to scientific investigation.

These products are strictly not for human or veterinary use, consumption, or diagnostic applications. They are not pharmaceuticals, food additives, or dietary supplements.

By purchasing from PrimalResearchLabs.com, you acknowledge that you are a qualified researcher operating in a controlled laboratory environment. Adhere to all applicable local, state, and federal laws and regulations regarding handling and use of research chemicals. Use appropriate personal protective equipment (PPE) and follow laboratory safety protocols.

Biology

Semaglutide is a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist engineered with structural modifications that enhance resistance to enzymatic degradation and prolong systemic half-life. It has been extensively studied in preclinical and clinical research models for its effects on glucose metabolism, insulin secretion, and appetite regulation.

Semaglutide stimulates insulin secretion in a glucose-dependent manner, suppresses glucagon release, delays gastric emptying, and reduces food intake via central nervous system pathways. Its prolonged activity profile and receptor specificity make it a valuable tool for in-vitro and in-vivo experimental design across diabetes research, obesity studies, and incretin biology.

This product is intended solely for in-vitro and preclinical research use and is not for human or veterinary consumption.

Key Research Applications of Semaglutide

1. GLP-1 Receptor Signaling & Glucose Regulation

Semaglutide demonstrates significant activity in metabolic studies through:

• Glucose-Dependent Insulin Secretion: Enhances insulin release in response to elevated glucose levels.
• Glucagon Suppression: Reduces glucagon secretion, improving glycemic control.
• Incretin Pathway Activation: Mimics endogenous GLP-1 activity in metabolic regulation.

Supporting Studies:
Marso, S.P. et al. — New England Journal of Medicine
“Semaglutide significantly improves glycemic control and reduces cardiovascular risk in type 2 diabetes.” ■ PubMed – PMID: 27633186

2. Appetite Regulation & Weight Management

Investigated in energy balance and obesity studies through:

• Appetite Suppression: Reduces food intake via hypothalamic signaling pathways.
• Gastric Emptying Delay: Slows gastric emptying, contributing to satiety.
• Weight Regulation Mechanisms: Demonstrates significant reductions in body weight in experimental models.

Supporting Studies:
Wilding, J.P.H. et al. — New England Journal of Medicine
“Once-weekly semaglutide in adults with overweight or obesity resulted in substantial weight loss.” ■ PubMed – PMID: 33567185

3. Metabolic Function & Cardiometabolic Research

Explored in broader metabolic studies through:

• Lipid Profile Modulation: Improves markers of lipid metabolism in research models.
• Insulin Sensitivity Enhancement: Supports improved insulin responsiveness.
• Cardiometabolic Pathway Research: Investigated in studies examining metabolic syndrome and related conditions.

Supporting Studies:
Davies, M. et al. — Lancet Diabetes & Endocrinology
“Semaglutide improves glycemic control and cardiometabolic parameters in type 2 diabetes.” ■ PubMed – PMID: 27126254

Recommended Research Concentrations

For laboratory research reference only. Not for human or veterinary use.

Why Choose Primal Research for Your Semaglutide Studies?

• ≥98% HPLC-verified purity — critical for GLP-1 receptor binding and metabolic pathway studies
• Independent third-party batch testing with COA available on request
• Lyophilized powder for maximum stability and long-term storage
• Available in 5mg, 10mg, and 20mg quantities — supports scalable metabolic research protocols

Storage & Handling

• Store at -20°C, desiccated and protected from light
• Soluble in sterile water or bacteriostatic water
• Prepare fresh solutions prior to each experiment
• Avoid repeated freeze-thaw cycles

Technical Specifications

• Compound: Semaglutide
• Molecular Weight: ~4113.6 g/mol
• Purity: ≥98% (HPLC Verified)
• Form: Lyophilized powder — 5mg, 10mg, and 20mg
• Storage: -20°C, desiccated, light-protected
• Solubility: Soluble in sterile water or bacteriostatic water
• COA: Available per batch on request

Advance Your Metabolic Research

Order your Semaglutide today to support advanced research in incretin biology, glucose regulation, and metabolic disease modeling.

Primal Research products are sold strictly for in-vitro and laboratory research use only. Not for human or veterinary consumption. Not intended to diagnose, treat, cure, or prevent any disease or condition. Purchasers are responsible for compliance with all applicable local, state, and federal regulations.